2.
维持药物治疗的AS患者具体用药种类及复发情况
Medications and disease recurrence in AS patients with maintenance medications
| Groups | Details of maintenance drugs and dosages | n | Recurrence [n (%)] | |
| - | + | |||
| TNFi withdrawal | ||||
| Celecoxib 200 mg/d | 10 | |||
| Loxoprofen 60 mg/d | 2 | |||
| Meloxicam 7.5 mg/d | 1 | |||
| SSZ 1.5 g/d | 2 | 16(72.7) | 6(27.3) | |
| MTX 10 mg/weeks+Meloxicam 7.5 mg/d | 2 | |||
| MTX 10 mg/weeks+Celecoxib 200 mg/d | 2 | |||
| SSZ 1.5 g/d+Meloxicam 7.5 mg/d | 2 | |||
| SSZ 1.5 g/d+Celecoxib 200 mg/d | 1 | |||
| TNFi reduction | ||||
| Etanercept 25 mg/weeks+Leflunomide 20 mg/d | 1 | |||
| Etanercept 25 mg/10 d+Celecoxib 200 mg/d | 11 | |||
| Etanercept 25 mg/10 d+Celecoxib 200 mg/d+Leflunomide 10 mg/d | 2 | |||
| Etanercept 25 mg/10 d+Celecoxib 200 mg/d+SSZ 1.5 g/d | 2 | 18(69.2) | 8(30.8) | |
| Etanercept 25 mg/10 d+Meloxicam 7.5 mg/d+SSZ1.5 g/d | 1 | |||
| Etanercept 25 mg/10 d | 7 | |||
| Inflixmab 200 mg/2 m | 1 | |||
| Adalimumab 40 mg/3 weeks | 1 | |||